SEC Filing Summary

Robert M. VanHimbergen, EVP and CFO of Elanco Animal Health Inc., reported a transaction involving 8.366 Deferred Stock Units on October 16, 2026. These units, representing the right to receive one share of the company's common stock or its cash equivalent, were acquired at a price of $23.55 per unit. Following this transaction, Mr. VanHimbergen now holds 175.9183 units. The deferred stock units are set to settle in cash or shares of common stock subsequent to his termination of employment or during a specified future year, as per the Executive Deferral and Stock Match Plan. This filing is classified as a change in officer position due to the nature of the transaction.